retatrutide trial results news today Retatrutide, a new weight loss drug not available on the market yet, is showing promising in trials. @DrLaPook explains it’s doing much more than what current medications can Lilly's 'triple G' agonist triumphs

When specific cells are capable of recognising GLP-1 through the use of GLP1R, the technical term is to say that they express GLP1R The net result is that the pancreas begins to secrete insulin after receiving GLP-1, thus ensuring that insulin release occurs shortly after a meal, which is required for normal healthy functioning

Two reported significant improvements in glycemic control, including a median reduction in hemoglobin A1C from 6.5% to 6.2% at 1 year among patients with IBD treated with a GLP-1 RA ( P =.01) and a mean A1C decrease of 0.76% (95% confidence interval, 0.99 to 0.52) among patients with IBD treated with tirzepatide

This can affect the timing and effectiveness of drugs like oral contraceptives, antibiotics, and other medications that require consistent absorption

Stay hydrated by sipping small amounts of water throughout the day

Although the researchers replicate a clinical trial finding of a reduction in heart attacks and strokes among patients with existing cardiovascular disease and chronic kidney disease and a reduction in moderate alcohol consumption risk, they find no statistically significant decline in broader emergency department visits or in any major diagnostic category